Related Articles
Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib
Changes in serum thymidine kinase 1 levels during chemotherapy correlate with objective response in patients with advanced gastric cancer
First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status
Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis Corrigendum in /10.3892/ol.2017.6082
Moderate dose-intensive chemotherapy for patients with non-small cell lung cancer: randomized trial, can it improve survival of patients with good performance status?